Strategic Global Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Strategic Global Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $141,489 - $158,359	-450 Reduced 5.52%	7,708 $2.71 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $191,746 - $218,738	-677 Reduced 7.66%	8,158 $2.57 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $40,292 - $45,328	-141 Reduced 1.57%	8,835 $2.55 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $69,278 - $77,299	-253 Reduced 2.74%	8,976 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $232,610 - $289,624	990 Added 12.02%	9,229 $2.6 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $64,654 - $76,203	292 Added 3.67%	8,239 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $110,100 - $138,985	622 Added 8.49%	7,947 $1.75 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $277,889 - $310,980	1,532 Added 26.45%	7,325 $1.33 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $118,681 - $139,956	-633 Reduced 9.85%	5,793 $1.17 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $74,734 - $87,112	-361 Reduced 5.32%	6,426 $1.38 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $32,500 - $43,346	-157 Reduced 2.26%	6,787 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $642,192 - $761,387	2,512 Added 56.68%	6,944 $1.89 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $268,772 - $352,593	1,192 Added 36.79%	4,432 $1.29 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $647,254 - $802,904	3,240 New	3,240 $771,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Global Advisors, LLC with notifications on news.